Engineering a Cure for Diabetes

Project Info.

Abstract

Background

Objective

Hypothesis

Procedures

Results

Future Work

Conclusions

Acknowledgements

References

Future Work

The transgenic plant-produced recombinant CTB-IL-13 protein is currently being used for a GM1 ELISA binding assay to determine if it can efficiently bind to mucosal receptors. Transgenic plant feeding trials will also be conducted to determine if they are effective in treating T1D.

http://www.jax.org/cranio/images/nm3283p%231816big.jpg